UBS Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $98.8M | Buy |
354,365
+138,179
| +64% | +$39.8M | 0.02% | 1063 |
|
|
2025
Q4 | $65.5M | Sell |
216,186
-14,533
| -6% | -$4.53M | 0.01% | 1363 |
|
|
2025
Q3 | $64.7M | Buy |
230,719
+29,955
| +15% | +$8.15M | 0.01% | 1383 |
|
|
2025
Q2 | $48.4M | Sell |
200,764
-16,872
| -8% | -$3.99M | 0.01% | 1554 |
|
|
2025
Q1 | $53M | Buy |
217,636
+138,350
| +174% | +$41.6M | 0.01% | 1426 |
|
|
2024
Q4 | $26M | Buy |
79,286
+50,059
| +171% | +$17M | 0.01% | 2048 |
|
|
2024
Q3 | $9.78M | Sell |
29,227
-23,683
| -45% | -$7.52M | ﹤0.01% | 2386 |
|
|
2024
Q2 | $14.5M | Sell |
52,910
-392
| -0.7% | -$114K | ﹤0.01% | 1940 |
|
|
2024
Q1 | $18.4M | Buy |
53,302
+17,806
| +50% | +$5.86M | 0.01% | 1762 |
|
|
2023
Q4 | $11.5M | Sell |
35,496
-4,431
| -11% | -$1.39M | ﹤0.01% | 1990 |
|
|
2023
Q3 | $14.3M | Buy |
39,927
+8,262
| +26% | +$3.19M | 0.01% | 1718 |
|
|
2023
Q2 | $12M | Buy |
31,665
+13,685
| +76% | +$5.57M | 0.01% | 1836 |
|
|
2023
Q1 | $8.61M | Buy |
17,980
+4,401
| +32% | +$2.06M | ﹤0.01% | 2003 |
|
|
2022
Q4 | $5.71M | Buy |
13,579
+7,281
| +116% | +$2.94M | ﹤0.01% | 2372 |
|
|
2022
Q3 | $2.63M | Sell |
6,298
-1,322
| -17% | -$659K | ﹤0.01% | 2917 |
|
|
2022
Q2 | $3.77M | Sell |
7,620
-9,363
| -55% | -$4.88M | ﹤0.01% | 2611 |
|
|
2022
Q1 | $9.56M | Sell |
16,983
-1,407
| -8% | -$848K | ﹤0.01% | 1979 |
|
|
2021
Q4 | $13.9M | Sell |
18,390
-3,044
| -14% | -$2.28M | 0.01% | 1851 |
|
|
2021
Q3 | $16M | Buy |
21,434
+2,618
| +14% | +$1.96M | 0.01% | 1672 |
|
|
2021
Q2 | $12.1M | Sell |
18,816
-8,512
| -31% | -$5.18M | 0.01% | 1870 |
|
|
2021
Q1 | $15.6M | Buy |
27,328
+7,468
| +38% | +$4.42M | 0.01% | 1612 |
|
|
2020
Q4 | $11.6M | Sell |
19,860
-16,417
| -45% | -$9.35M | 0.01% | 1746 |
|
|
2020
Q3 | $18.7M | Sell |
36,277
-19,228
| -35% | -$9.74M | 0.01% | 1216 |
|
|
2020
Q2 | $25.1M | Sell |
55,505
-21,029
| -27% | -$9.28M | 0.01% | 962 |
|
|
2020
Q1 | $26.8M | Sell |
76,534
-2,379
| -3% | -$875K | 0.02% | 842 |
|
|
2019
Q4 | $29.2M | Buy |
78,913
+10,719
| +16% | +$3.78M | 0.01% | 1114 |
|
|
2019
Q3 | $22.7M | Sell |
68,194
-18,219
| -21% | -$5.94M | 0.01% | 1152 |
|
|
2019
Q2 | $27M | Buy |
86,413
+2,311
| +3% | +$692K | 0.01% | 1016 |
|
|
2019
Q1 | $25.7M | Sell |
84,102
-39,269
| -32% | -$10.6M | 0.01% | 990 |
|
|
2018
Q4 | $28.6M | Buy |
123,371
+32,231
| +35% | +$8.65M | 0.02% | 859 |
|
|
2018
Q3 | $28.5M | Buy |
91,140
+18,346
| +25% | +$5.69M | 0.01% | 972 |
|
|
2018
Q2 | $21M | Buy |
72,794
+45,911
| +171% | +$12.7M | 0.01% | 1136 |
|
|
2018
Q1 | $6.72M | Sell |
26,883
-345
| -1% | -$87.8K | ﹤0.01% | 2041 |
|
|
2017
Q4 | $6.5M | Buy |
27,228
+2,184
| +9% | +$529K | ﹤0.01% | 2095 |
|
|
2017
Q3 | $5.57M | Sell |
25,044
-1,323
| -5% | -$298K | ﹤0.01% | 2105 |
|
|
2017
Q2 | $5.97M | Sell |
26,367
-642
| -2% | -$140K | ﹤0.01% | 1989 |
|
|
2017
Q1 | $5.38M | Buy |
27,009
+18,633
| +222% | +$3.59M | ﹤0.01% | 2032 |
|
|
2016
Q4 | $1.53M | Buy |
8,376
+84
| +1% | +$14.3K | ﹤0.01% | 3165 |
|
|
2016
Q3 | $1.36M | Sell |
8,292
-3,267
| -28% | -$496K | ﹤0.01% | 3179 |
|
|
2016
Q2 | $1.65M | Sell |
11,559
-1,084
| -9% | -$155K | ﹤0.01% | 2931 |
|
|
2016
Q1 | $1.73M | Sell |
12,643
-1,686
| -12% | -$221K | ﹤0.01% | 2808 |
|
|
2015
Q4 | $1.99M | Sell |
14,329
-340
| -2% | -$47.1K | ﹤0.01% | 2794 |
|
|
2015
Q3 | $1.97M | Sell |
14,669
-1,473
| -9% | -$212K | ﹤0.01% | 2752 |
|
|
2015
Q2 | $2.43M | Sell |
16,142
-41,252
| -72% | -$5.9M | ﹤0.01% | 2795 |
|
|
2015
Q1 | $7.76M | Buy |
57,394
+41,855
| +269% | +$5.19M | 0.01% | 1685 |
|
|
2014
Q4 | $1.87M | Buy |
+15,539
| New | +$1.79M | ﹤0.01% | 2966 |
|
Other funds holding BIO
VCM
VPM
AI
